|
| CR | PR | SD | PD | ORR | DCR |
| 总体(43) | 0 | 7 | 22 | 14 | 16.3 | 67.4% |
| 抗肺癌抗结核同时治疗组(6) | 0 | 0 | 5 | 1 | 0% | 83.3%% |
| 单独使用抗癌药物组(37) | 0 | 7 | 17 | 13 | 18.9% | 64.9% |